Toronto, Ontario–(Newsfile Corp. – July 9, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws, is thrilled to announce the culmination of an innovative research collaboration with Professor David Nutt and Drug Science, the UK’s preeminent independent scientific body on drug research. This landmark study, leveraging data from Red Light Holland’s state-of-the-art microdosing application (https://imicroapp.com), provides anonymized, user-consented insights into the multifaceted applications and gender-specific effects of psilocybin microdosing.
Under the aegis of Professor David Nutt, a luminary in neuropsychopharmacology, the collaboration harnessed real-world data from 929 individuals engaging with psilocybin in the Netherlands’ regulated market. The analysis elucidated distinct usage patterns and sex-based variances, underscoring the nuanced therapeutic potential of microdosing.
- Significant gender differences in dosing schedules, with females showing higher adherence in certain age brackets.
- A high proportion of female participants, an anomaly compared to typical microdosing studies which often report less than 30% female involvement.
- Potential therapeutic implications for conditions disproportionately affecting women, such as PMS, menopause, and migraines.
- Experienced microdosers adhering to consistent schedules
“This pioneering study with Professor Nutt and Drug Science solidifies our commitment to advancing psilocybin research based on empirical data,” stated Todd Shapiro, CEO of Red Light Holland. “Our findings advocate for emerging markets to streamline access to sub-hallucinogenic doses of psilocybin, offering a natural, non-addictive alternative for individuals battling migraines, OCD, depression, PMS, and menopause. As well, we plan on sharing our results with our personal connections with Government officials in Canada, as we continue to push for the ‘right to try psilocybin’ for those in need.”
CTIO Sarit Hashkes emphasized, “The real-world data from the Netherlands, where psilocybin truffles are legally available, provides invaluable insights for regulatory bodies worldwide. Our research on sex differences and user experience levels is crucial for shaping informed, safe, and effective psilocybin therapies. Promoting global legal access to such a promising substance is imperative for addressing the healthcare needs of billions, particularly those often underrepresented in medical research.”
The detailed results of this transformative research will be presented to the international consortium of companies participating in Drug Science’s bi-monthly meetings, paving the way for future advancements and regulatory discussions in the realm of psilocybin microdosing.
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws.